Literature DB >> 8429306

Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus.

J A Walker1, Y Kawaoka.   

Abstract

The virulence of avian influenza A viruses depends on the cleavability of the haemagglutinin (HA) by an intracellular protease at multiple basic amino acids. Although previous studies have demonstrated the importance of these amino acids for processing by the cellular protease, with emphasis on conserved residues near the cleavage site, the minimal requirements for cleavage remain unknown. By expressing site-specific mutants of the HA of a virulent avian influenza virus, A/turkey/Ireland/1378/85 (H5N8), in the simian virus 40 system and testing for their cleavability by an endogenous protease in CV-1 cells, and their fusion activity in a polykaryon formation assay, we were able to show that glycine at the amino terminus of HA2 is not essential for cleavage and that maximal cleavage requires at least five basic residues at the cleavage site, when carbohydrate is nearby. Moreover, we confirmed, that a conserved proline upstream of the cleavage site is not essential for HA cleavage or fusion activity, and that lysine replacement of the carboxyl-terminal arginine of HA1 abolishes cleavability. These findings should help identify the proteases responsible for intracellular cleavage of the HA of virulent avian influenza viruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429306     DOI: 10.1099/0022-1317-74-2-311

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.

Authors:  H Qiao; R T Armstrong; G B Melikyan; F S Cohen; J M White
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Characterization of an H4N2 influenza virus from Quails with a multibasic motif in the hemagglutinin cleavage site.

Authors:  Sook-San Wong; Sun-Woo Yoon; Mark Zanin; Min-Suk Song; Christine Oshansky; Hassan Zaraket; Stephanie Sonnberg; Adam Rubrum; Patrick Seiler; Angela Ferguson; Scott Krauss; Carol Cardona; Richard J Webby; Beate Crossley
Journal:  Virology       Date:  2014-08-23       Impact factor: 3.616

Review 3.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

4.  Acquisition of a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular cleavage of an H7N7 influenza virus hemagglutinin.

Authors:  Brian S Hamilton; Xiangjie Sun; Changik Chung; Gary R Whittaker
Journal:  Virology       Date:  2012-10-07       Impact factor: 3.616

5.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.

Authors:  D M Milewicz; J Grossfield; S N Cao; C Kielty; W Covitz; T Jewett
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 6.  Mucosal vaccines for the prevention of influenza.

Authors:  R L Clancy
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

7.  Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.

Authors:  K J Cross; S A Wharton; J J Skehel; D C Wiley; D A Steinhauer
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

8.  Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus.

Authors:  T Horimoto; Y Kawaoka
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses.

Authors:  T Horimoto; K Nakayama; S P Smeekens; Y Kawaoka
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.